hrcak mascot   Srce   HID

Izvorni znanstveni članak
https://doi.org/10.21860/52;3_390

Impact of bone marrow angiogenesis, expression of osteopontin and vascular endothelial growth factor on myeloma patient response to the first line therapy

Emina Babarović ; Zavod za patologiju i patološku anatomiju, Medicinski fakultet Sveučilišta u Rijeci, Rijeka
Ita Hadžisejdić ; Zavod za patologiju i patološku anatomiju, Medicinski fakultet Sveučilišta u Rijeci, Rijeka
Sanja Štifter ; Zavod za patologiju i patološku anatomiju, Medicinski fakultet Sveučilišta u Rijeci, Rijeka
Ksenija Lučin ; Zavod za patologiju i patološku anatomiju, Medicinski fakultet Sveučilišta u Rijeci, Rijeka
Nives Jonjić ; Zavod za patologiju i patološku anatomiju, Medicinski fakultet Sveučilišta u Rijeci, Rijeka

Puni tekst: hrvatski, pdf (1 MB) str. 390-399 preuzimanja: 215* citiraj
APA 6th Edition
Babarović, E., Hadžisejdić, I., Štifter, S., Lučin, K. i Jonjić, N. (2016). Utjecaj angiogeneze, izražaja osteopontina i vaskularnog endotelnog čimbenika rasta u koštanoj srži na odgovor na prvu liniju terapije u pacijenata s multiplim mijelomom. Medicina Fluminensis, 52 (3), 390-399. https://doi.org/10.21860/52;3_390
MLA 8th Edition
Babarović, Emina, et al. "Utjecaj angiogeneze, izražaja osteopontina i vaskularnog endotelnog čimbenika rasta u koštanoj srži na odgovor na prvu liniju terapije u pacijenata s multiplim mijelomom." Medicina Fluminensis, vol. 52, br. 3, 2016, str. 390-399. https://doi.org/10.21860/52;3_390. Citirano 09.04.2020.
Chicago 17th Edition
Babarović, Emina, Ita Hadžisejdić, Sanja Štifter, Ksenija Lučin i Nives Jonjić. "Utjecaj angiogeneze, izražaja osteopontina i vaskularnog endotelnog čimbenika rasta u koštanoj srži na odgovor na prvu liniju terapije u pacijenata s multiplim mijelomom." Medicina Fluminensis 52, br. 3 (2016): 390-399. https://doi.org/10.21860/52;3_390
Harvard
Babarović, E., et al. (2016). 'Utjecaj angiogeneze, izražaja osteopontina i vaskularnog endotelnog čimbenika rasta u koštanoj srži na odgovor na prvu liniju terapije u pacijenata s multiplim mijelomom', Medicina Fluminensis, 52(3), str. 390-399. https://doi.org/10.21860/52;3_390
Vancouver
Babarović E, Hadžisejdić I, Štifter S, Lučin K, Jonjić N. Utjecaj angiogeneze, izražaja osteopontina i vaskularnog endotelnog čimbenika rasta u koštanoj srži na odgovor na prvu liniju terapije u pacijenata s multiplim mijelomom. Medicina Fluminensis [Internet]. 2016 [pristupljeno 09.04.2020.];52(3):390-399. https://doi.org/10.21860/52;3_390
IEEE
E. Babarović, I. Hadžisejdić, S. Štifter, K. Lučin i N. Jonjić, "Utjecaj angiogeneze, izražaja osteopontina i vaskularnog endotelnog čimbenika rasta u koštanoj srži na odgovor na prvu liniju terapije u pacijenata s multiplim mijelomom", Medicina Fluminensis, vol.52, br. 3, str. 390-399, 2016. [Online]. https://doi.org/10.21860/52;3_390

Sažetak
Objective: To investigate the effect of angiogenic parameters, expression of osteopontin (OPN) and vascular endothelial growth factor (VEGF) in the bone marrow in order to predict response to first-line therapy in patients with multiple myeloma (MM). Patients and Methods: The study included 68 patients with MM, treated at the Department of Hematology, Clinical Hospital Centre in Rijeka. For quantification of angiogenic parameters besides the classical method of determining microvessel density (MVD) we used a computer assisted image analysis which enabled us to calculate the number of blood vessels per mm2, the surface of blood vessels per mm2, an average diameter of blood vessels and total vascular surface (TVA) in the bone marrow biopsies stained with anti-CD34. To determine the expression of OPN and VEGF in plasma cells we used double staining immunohistochemistry method, CD138+OPN and CD138+VEGF. Results: We found that a higher angiogenic parameters, the MVD (P = 0.004) and the number of blood vessels per mm2 (P = 0.028), were significantly negative prognostic indicator of response to the first-line therapy in patients with MM. Conclusion: An objective method of the assessment of angiogenesis in the bone marrow samples could become a part of the routine histopathological analysis which could help to identify a subgroup of patients with possible aggressive course and poor response to the therapy.

Ključne riječi
angiogenesis; immunohistochemistry; multiple myeloma; osteopontin; prognosis; vascular endothelial growth factor

Hrčak ID: 163943

URI
https://hrcak.srce.hr/163943

[hrvatski]

Posjeta: 387 *